The Safest Way To Start Trading Is Here!
One look at Wall Street right now and anyone can tell: it’s a mess! But new trades can get an edge with “Options Trading Made Easy” by trading champion Chuck Hughes, the best guide to options trading in the modern market.

Start with a small investment today and see where you can go!

Get your copy now!
>>>

GANX Insider Trading (Gain Therapeutics)

Insider Ownership Percentage: 11.00%
Insider Buying (Last 12 Months): $17,243.56
Insider Selling (Last 12 Months): $0.00

Gain Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Gain Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Gain Therapeutics Share Price & Price History

Current Price: $3.60
Price Change: Price Increase of +0.01 (0.28%)
As of 06/30/2022 05:00 PM ET

This chart shows the closing price history over time for GANX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
This Has Won 99.1% Of Trades Over 3 Years
Video reveals the most powerful trade you’ve NEVER heard of. Released every Tuesday, it could DOUBLE your money by Friday.

In past 3 years, it’s won 321 out of 324 of these trades, with the majority making 100%+ every 3-10 days.

See how a simple 10-minute trade on Tue could double your money by Fri.

Watch Video Now For Full Details.
>>>

Gain Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/25/2022Eric I RichmanCEOBuy2,482$2.58$6,403.56217,729View SEC Filing Icon  
5/19/2022Eric I RichmanCEOBuy4,000$2.71$10,840.00205,991View SEC Filing Icon  
See Full Table
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.

SEC Filings (Institutional Ownership Changes) for Gain Therapeutics (NASDAQ:GANX)

8.89% of Gain Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at GANX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Gain Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2022Jane Street Group LLC11,722$48K0.0%N/A0.099%Search for SEC Filing on Google Icon
5/17/2022Royal Bank of Canada50,000$0.21M0.0%+373.5%0.421%Search for SEC Filing on Google Icon
5/9/2022CM Management LLC125,000$0.51M0.4%+38.9%1.052%Search for SEC Filing on Google Icon
2/3/2022Advisor Group Holdings Inc.10,050$54K0.0%N/A0.085%Search for SEC Filing on Google Icon
2/2/2022CM Management LLC90,000$0.49M0.4%+39.9%0.758%Search for SEC Filing on Google Icon
11/16/2021Telemetry Investments L.L.C.96,232$0.72M1.0%+217.7%0.810%Search for SEC Filing on Google Icon
11/15/2021Veritable L.P.25,064$0.19M0.0%N/A0.211%Search for SEC Filing on Google Icon
11/9/2021Indie Asset Partners LLC29,652$0.22M0.2%N/A0.250%Search for SEC Filing on Google Icon
11/8/2021CM Management LLC64,327$0.48M0.4%+543.3%0.542%Search for SEC Filing on Google Icon
8/17/2021Bridgeway Capital Management LLC50,000$0.50M0.0%N/A0.421%Search for SEC Filing on Google Icon
8/16/2021Telemetry Investments L.L.C.30,293$0.30M0.4%N/A0.255%Search for SEC Filing on Google Icon
8/11/2021Banque Cantonale Vaudoise3,000$30K0.0%N/A0.025%Search for SEC Filing on Google Icon
8/10/2021CM Management LLC10,000$100K0.1%N/A0.084%Search for SEC Filing on Google Icon
5/27/2021Davidson Kempner Capital Management LP15,000$0.22M0.0%N/A0.126%Search for SEC Filing on Google Icon
5/19/2021Worth Venture Partners LLC15,532$0.23M0.1%N/A0.131%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC14,367$0.21M0.0%N/A0.121%Search for SEC Filing on Google Icon
5/18/2021Greenlight Capital Inc.546,560$8.16M0.6%N/A4.602%Search for SEC Filing on Google Icon
5/18/2021Davidson Kempner Capital Management LP15,000$0.22M0.0%N/A0.126%Search for SEC Filing on Google Icon
5/18/2021Jane Street Group LLC22,754$0.34M0.0%N/A0.192%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Gain Therapeutics logo
Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietary small molecules that bind these sites, restore protein folding, and treat disease. It is developing structurally targeted allosteric regulator candidates to treat various diseases, including Morquio B, GM1 gangliosidosis (GM1), neuronopathic Gaucher disease, GBA1 Parkinson's, Krabbe, and Mucopolysaccharidosis type 1 diseases. The company was founded in 2017 and is based in Bethesda, Maryland.
Read More on Gain Therapeutics

Today's Range

Now: $3.60
Low: $3.53
High: $3.67

50 Day Range

MA: $3.28
Low: $2.56
High: $4.20

52 Week Range

Now: $3.60
Low: $2.33
High: $10.48

Volume

13,756 shs

Average Volume

110,952 shs

Market Capitalization

$42.78 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.36

Who are the company insiders with the largest holdings of Gain Therapeutics?

Gain Therapeutics' top insider investors include:
  1. Eric I Richman (CEO)
Learn More about top insider investors at Gain Therapeutics.
The Safest Way To Start Trading Is Here!
One look at Wall Street right now and anyone can tell: it’s a mess! But new trades can get an edge with “Options Trading Made Easy” by trading champion Chuck Hughes, the best guide to options trading in the modern market.

Start with a small investment today and see where you can go!

Get your copy now!
>>>